Published in Oncotarget on September 08, 2015
Regulation of Natural Killer Cell Function by STAT3. Front Immunol (2016) 0.76
Novel Strategy to Expand Super-Charged NK Cells with Significant Potential to Lyse and Differentiate Cancer Stem Cells: Differences in NK Expansion and Function between Healthy and Cancer Patients. Front Immunol (2017) 0.75
Biology of natural killer cells. Adv Immunol (1989) 14.77
Aberrant rel/nfkb genes and activity in human cancer. Oncogene (1999) 5.62
Lysosomal cysteine proteases: facts and opportunities. EMBO J (2001) 3.06
Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest (2002) 2.56
Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res (2012) 2.54
Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo. Proc Natl Acad Sci U S A (1999) 2.48
Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology (2009) 2.45
Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol (2004) 2.44
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood (2007) 2.35
The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett (1991) 2.33
Lysosomal cysteine proteases regulate antigen presentation. Nat Rev Immunol (2003) 2.25
Tumor exosomes inhibit differentiation of bone marrow dendritic cells. J Immunol (2007) 2.16
Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res (1993) 1.95
Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol (2003) 1.67
Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood (2000) 1.62
Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J Immunol (2004) 1.57
Reorientation and fusion of cytotoxic T lymphocyte granules after interaction with target cells as determined by high resolution cinemicrography. J Immunol (1986) 1.47
Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. Clin Cancer Res (1996) 1.46
The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments. J Cell Biol (1990) 1.39
Papillon-Lefèvre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C/dipeptidyl peptidase I deficiency in humans. J Immunol (2004) 1.36
Evolution of proteins of the cystatin superfamily. J Mol Evol (1990) 1.34
Oligomeric structure and substrate induced inhibition of human cathepsin C. J Biol Chem (1995) 1.30
Target-induced inactivation and cell death by apoptosis in a subset of human NK cells. J Immunol (1996) 1.30
Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor. J Cell Biol (1993) 1.29
Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing. Biochemistry (2001) 1.26
Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulators. Curr Pharm Des (2002) 1.23
Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. Int Immunol (2002) 1.23
Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancer. Clin Cancer Res (1999) 1.17
Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J Immunol (2007) 1.14
T cell receptor-zeta and granzyme B expression in mononuclear cell infiltrates in normal colon mucosa and colon carcinoma. Gut (1997) 1.14
Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I. J Immunol (1995) 1.13
Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells. J Immunol (1997) 1.11
Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset. Cell Immunol (1995) 1.11
Cystatin F is a cathepsin C-directed protease inhibitor regulated by proteolysis. EMBO J (2008) 1.04
Inhibition of nuclear factor kappa B (NFkappaB) activity in oral tumor cells prevents depletion of NK cells and increases their functional activation. Cancer Immunol Immunother (2005) 1.04
Cystatins. Methods Enzymol (1994) 1.03
Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells. Clin Cancer Res (2006) 1.02
Cytokine dependent inverse regulation of CD54 (ICAM1) and major histocompatibility complex class I antigens by nuclear factor kappaB in HEp2 tumor cell line: effect on the function of natural killer cells. Hum Immunol (2003) 0.99
Cathepsin H is an additional convertase of pro-granzyme B. J Biol Chem (2010) 0.99
Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins. PLoS Pathog (2012) 0.98
Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J Biol Chem (1998) 0.97
Structural basis of reduction-dependent activation of human cystatin F. J Biol Chem (2006) 0.97
Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis. J Cell Biol (2007) 0.97
Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab')2 fragment of anti-CD16 antibody. Cancer Immunol Immunother (2008) 0.95
Strategies to rescue mesenchymal stem cells (MSCs) and dental pulp stem cells (DPSCs) from NK cell mediated cytotoxicity. PLoS One (2010) 0.95
Inhibitory properties of cystatin F and its localization in U937 promonocyte cells. FEBS J (2005) 0.93
Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation. J Clin Immunol (1996) 0.92
Stoichiometry and heterogeneity of the pro-region chain in tetrameric human cathepsin C. Biochim Biophys Acta (1998) 0.92
Cystatin F is secreted, but artificial modification of its C-terminus can induce its endocytic targeting. Exp Cell Res (2004) 0.91
Leukocystatin, a new Class II cystatin expressed selectively by hematopoietic cells. J Biol Chem (1998) 0.91
Recombinant human cathepsin H lacking the mini chain is an endopeptidase. Biochemistry (2003) 0.89
Glycosylation directs targeting and activation of cystatin f from intracellular and extracellular sources. Traffic (2009) 0.89
Rebuilding immunity in cancer patients. Blood Cells Mol Dis (2007) 0.88
Regulation of cathepsins S and L by cystatin F during maturation of dendritic cells. Eur J Cell Biol (2012) 0.87
Target cell directed NK inactivation. Concomitant loss of NK and antibody-dependent cellular cytotoxicity activities. J Immunol (1988) 0.86
Regulated expression and intracellular localization of cystatin F in human U937 cells. Eur J Biochem (2002) 0.86
Purification and characterization of cathepsin J from rat liver. Eur J Biochem (1992) 0.86
CMAP: a novel cystatin-like gene involved in liver metastasis. Cancer Res (1999) 0.84
Cysteine cathepsins: regulators of antitumour immune response. Expert Opin Biol Ther (2006) 0.82
Cystatin F regulates proteinase activity in IL-2-activated natural killer cells. Protein Pept Lett (2014) 0.80
Internalization of exogenous cystatin F supresses cysteine proteases and induces the accumulation of single-chain cathepsin L by multiple mechanisms. J Biol Chem (2011) 0.79
Inhibition of human natural killer activity by monolayers of primary cell cultures. Nat Immun Cell Growth Regul (1987) 0.79
The influence of differential processing of procathepsin H on its aminopeptidase activity, secretion and subcellular localization in human cell lines. Eur J Cell Biol (2012) 0.77